2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the task force on the management of elevated blood pressure …
JW McEvoy, CP McCarthy, RM Bruno… - European heart …, 2024 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
Acute aortic dissection
T Carrel, TM Sundt, Y von Kodolitsch, M Czerny - The Lancet, 2023 - thelancet.com
Although substantial progress has been made in the prevention, diagnosis, and treatment of
acute aortic dissection, it remains a complex cardiovascular event, with a high immediate …
acute aortic dissection, it remains a complex cardiovascular event, with a high immediate …
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …
G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases: Developed by the task force on the management of peripheral arterial and aortic …
L Mazzolai, G Teixido-Tura, S Lanzi, V Boc… - European heart …, 2024 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
[PDF][PDF] 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …
M Brunström, M Burnier… - Journal of …, 2023 - docred-strapi-cms-prod.s3.sa-east-1 …
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022
Cardiovascular diseases (CVD) remain the leading cause of death worldwide, and
pharmacotherapy of most of them is suboptimal. Thus, there is a clear unmet clinical need to …
pharmacotherapy of most of them is suboptimal. Thus, there is a clear unmet clinical need to …
Endothelial HDAC1-ZEB2-NuRD complex drives aortic aneurysm and dissection through regulation of protein S-sulfhydration
S Luo, C Kong, S Zhao, X Tang, Y Wang, X Zhou, R Li… - Circulation, 2023 - Am Heart Assoc
Background: Aortic aneurysm and aortic dissection (AAD) are life-threatening vascular
diseases, with endothelium being the primary target for AAD treatment. Protein S …
diseases, with endothelium being the primary target for AAD treatment. Protein S …
[HTML][HTML] A review of polypills for the prevention of atherosclerotic cardiovascular disease
F Agnello, S Finocchiaro, C Laudani, M Legnazzi… - American heart …, 2023 - Elsevier
Atherosclerotic cardiovascular disease (ASCVD) is a prevalent chronic condition managed
through pharmacotherapy targeting modifiable risk factors. However, ASCVD patients often …
through pharmacotherapy targeting modifiable risk factors. However, ASCVD patients often …
Endothelial dysfunction in Marfan syndrome mice is restored by resveratrol
A Mieremet, M van der Stoel, S Li, E Coskun… - Scientific reports, 2022 - nature.com
Patients with Marfan syndrome (MFS) develop thoracic aortic aneurysms as the aorta
presents excessive elastin breaks, fibrosis, and vascular smooth muscle cell (vSMC) death …
presents excessive elastin breaks, fibrosis, and vascular smooth muscle cell (vSMC) death …
The aortic team model and collaborative decision pathways for the management of complex aortic disease: clinical practice update from the Canadian Cardiovascular …
RS McClure, TF Lindsay, M Keir, JP Bayne… - Canadian Journal of …, 2023 - Elsevier
Disease of the aortic arch, descending thoracic, or thoracoabdominal aorta necessitates
dedicated expertise across medical, endovascular, and surgical specialties. Cardiologists …
dedicated expertise across medical, endovascular, and surgical specialties. Cardiologists …